Outcomes of clinical utility in amyloid-PET studies: state of art and future perspectives

202132 citationsReviewhybrid Open Access

Authors

Matteo Cotta Ramusino · University of Pavia

Giulia Perini · University of Pavia

Daniele Altomare · University of Geneva

Paola Barbarino · Alzheimer Disease International

Wendy Weidner · Alzheimer Disease International

G Porro

Frederik Barkhof · Queen Mary University of London

Abstract

Current studies validating amyloid-PET already assessed outcomes for clinical utility, although non-clinician-based outcomes were inconsistent. A wider participation of stakeholders may help produce a more thorough and systematic definition and assessment of outcomes of clinical utility and help collect evidence informing decisions on reimbursement of amyloid-PET.

Topics & Keywords

Dementia and Cognitive Impairment Research Health Systems, Economic Evaluations, Quality of Life Amyloidosis: Diagnosis, Treatment, Outcomes

UN Sustainable Development Goals

Partnerships for the goals

Publication Details

Published in: European Journal of Nuclear Medicine and Molecular Imaging

Volume 48, Issue 7, pp. 2157-2168

DOI: 10.1007/s00259-020-05187-x

Field-Weighted Citation Impact: 3.97